B:Havior IVS: Financial statements 2019
CVR: 38277022
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
B:Havior IVS (CVR 38277022) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -3,125 and a net result of DKK -3,125 compared with DKK 18,859 the year before. Equity in the 2019 report amounted to DKK 15,734. The solvency ratio was 83.4%.
- Gross Profit
- DKK -3,125
- Profit/Loss
- DKK -3,125
- Equity
- DKK 15,734
- Total Assets
- DKK 18,859
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -3 t. | -3 t. | 16 t. | - |
| 2018 | 103 t. | 19 t. | 19 t. | 19 t. | - |
| 2017 | 0 | 0 | 0 | 1 | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 3, 2019, Michael Kayser is registered as adm. dir. of B:Havior IVS.
As of September 3, 2019, Mathias Haastrup has stepped down as adm. dir. of B:Havior IVS.
B:Havior IVS has published its annual report for 2018. Revenue came to DKK 102,950, and the net result was DKK 18,859.
On June 10, 2019, the company changed its name from SEPAS Health IVS to B:Havior IVS.
As of June 1, 2019, Mathias Haastrup is registered as adm. dir. of B:Havior IVS.
As of May 31, 2019, Niklas Windolf-Vestergaard has stepped down as adm. dir. of B:Havior IVS.
About B:Havior IVS
B:Havior IVS was a Danish company of the type Iværksætterselskab based in Rødovre, founded in 2016. The company has been dissolved on 10 November 2021. The company was registered under the industry Sundhedsvæsen i øvrigt i.a.n.. The company was previously named SEPAS Health IVS. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -3,125 the year before. Equity in the 2020 report amounted to DKK 0.